Medical Journals

Phospholipase C-related Inactive Protein is Involved in Trafficking of Gamma2 Subunit-containing Gaba(A) Receptors to the Cell Surface.

Authors:
  • Mizokami Akiko
  • Kanematsu Takashi
  • Ishibashi Hitoshi
  • Yamaguchi Taku
  • Tanida Isei
  • Takenaka Kei
  • Nakayama Keiichi I
  • Fukami Kiyoko
  • Takenawa Tadaomi
  • Kominami Eiki
  • Moss Stephen J
  • Yamamoto Tsuneyuki
  • Nabekura Junichi
  • Hirata Masato

From: Laboratory of Molecular and Cellular Biochemistry, Faculty of Dental Science, and Station for Collaborative Research, Kyushu University, Fukuoka 812-8582, Japan.

The Journal of neuroscience : the official journal of the Society for Neuroscience

  • Publish Date: Feb 2007
  • ISSN: 1529-2401
  • Volume: 27
  • Issue: 7
  • Pages: 1692-701
  • Medium: Internet
  • Language: English
  • Citation (JAMA): Mizokami Akiko, Kanematsu Takashi, Ishibashi Hitoshi, et al. Phospholipase C-related Inactive Protein is Involved in Trafficking of Gamma2 Subunit-containing Gaba(A) Receptors to the Cell Surface.. J. Neurosci. Feb 2007;27:1692-701

Abstract

The subunit composition of GABA(A) receptors is known to be associated with distinct physiological and pharmacological properties. Previous studies that used phospholipase C-related inactive protein type 1 knock-out (PRIP-1 KO) mice revealed that PRIP-1 is involved in the assembly and/or the trafficking of gamma2 subunit-containing GABA(A) receptors. There are two PRIP genes in mammals; thus the roles of PRIP-1 might be compensated partly by those of PRIP-2 in PRIP-1 KO mice. Here we used PRIP-1 and PRIP-2 double knock-out (PRIP-DKO) mice and examined the roles for PRIP in regulating the trafficking of GABA(A) receptors. Consistent with previous results, sensitivity to diazepam was reduced in electrophysiological and behavioral analyses of PRIP-DKO mice, suggesting an alteration of gamma2 subunit-containing GABA(A) receptors. The surface numbers of diazepam binding sites (alpha/gamma2 subunits) assessed by [3H]flumazenil binding were reduced in the PRIP-DKO mice as compared with those of wild-type mice, whereas the cell surface GABA binding sites (alpha/beta subunits, assessed by [3H]muscimol binding) were increased in PRIP-DKO mice. The association between GABA(A) receptors and GABA(A) receptor-associated protein (GABARAP) was reduced significantly in PRIP-DKO neurons. Disruption of the direct interaction between PRIP and GABA(A) receptor beta subunits via the use of a peptide corresponding to the PRIP-1 binding site reduced the cell surface expression of gamma2 subunit-containing GABA(A) receptors in cultured cell lines and neurons. These results suggest that PRIP is implicated in the trafficking of gamma2 subunit-containing GABA(A) receptors to the cell surface, probably by acting as a bridging molecule between GABARAP and the receptors.

Mesh Headings (Keywords): Animals, Animals, Newborn, Behavior, Animal, Carrier Proteins, Cells, Cultured, Dose-Response Relationship, Drug, Enzyme-Linked Immunosorbent Assay, GABA Agents, Hippocampus, Humans, Immunoprecipitation, Male, Membrane Potentials, Mice, Mice, Inbred C57BL, Mice, Knockout, Neurons, Patch-Clamp Techniques, Protein Binding, Protein Subunits, Protein Transport, RNA, Messenger, Receptors, GABA-A, Reverse Transcriptase Polymerase Chain Reaction, Transfection


Check for Full Text / PubMed Unique Identifier (PMID): 17301177


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.